Transforming growth factor-beta receptor expression in human cornea

Area of Science:

• Ophthalmology
• Cell Biology
• Molecular Biology

Background:

• Limbal basal cells and corneal endothelial cells exhibit G1 phase cell cycle inhibition.
• Transforming growth factor-beta (TGF-beta) is a potential mediator of this cell cycle inhibition.

Purpose of the Study:

• To investigate the expression of TGF-beta receptor types I (RI), II (RII), and III (RIII) in human corneal and limbal cells.
• To determine if these cells possess the necessary components to transduce TGF-beta signals.

Main Methods:

• Human corneas from various ages were analyzed using indirect immunofluorescence for receptor protein localization.
• Reverse transcription-polymerase chain reaction (RT-PCR) was employed to detect receptor mRNA in corneal epithelium and endothelium.

Main Results:

• RI and RII were detected in limbal basal cells and corneal endothelium, with minimal expression in central corneal epithelium.
• RIII was found in all corneal epithelium layers and suprabasal limbal layers, but decreased in limbal basal cells; corneal endothelium showed strong RIII staining.
• Both mRNA and protein for all three TGF-beta receptor types were confirmed in corneal epithelium and endothelium.

Conclusions:

• Human limbal basal cells and corneal endothelial cells express all three TGF-beta receptor types, suggesting they can receive TGF-beta signals.
• Differential expression of RIII between limbal basal cells and corneal endothelium may indicate varied responses to specific TGF-beta isoforms.
• The presence of TGF-beta receptors supports the hypothesis that TGF-beta mediates G1 phase arrest in these ocular cell types.